29102-47-4 Usage
Uses
Used in Cancer Treatment:
2-(aziridin-1-yl)-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide is used as an alkylating agent for the treatment of various types of cancer. Its alkylating properties enable it to cause DNA damage in rapidly dividing cancer cells, leading to their death. This makes it a valuable tool in the fight against cancer.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-(aziridin-1-yl)-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide is used as a key component in the development of cancer therapeutics. Its unique properties and effectiveness in targeting rapidly dividing cancer cells make it a promising candidate for the creation of new and improved cancer treatments.
Used in Research and Development:
2-(aziridin-1-yl)-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide is also used in research and development for the discovery of potential new therapeutic applications. Its alkylating properties and ability to target cancer cells make it an interesting compound for further study and exploration in the field of oncology.
Check Digit Verification of cas no
The CAS Registry Mumber 29102-47-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,1,0 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 29102-47:
(7*2)+(6*9)+(5*1)+(4*0)+(3*2)+(2*4)+(1*7)=94
94 % 10 = 4
So 29102-47-4 is a valid CAS Registry Number.
29102-47-4Relevant academic research and scientific papers
Synthesis and Antitumor Activity of Analogues of Ifosfamide Modified in the N-(2-Chloroethyl) Group
Misiura, Konrad,Kinas, Ryszard W.,Stec, Wojciech J.,Kusnierczyk, Halina,Radzikowski, Czeslaw,Sonoda, Akio
, p. 226 - 230 (2007/10/02)
A series of 3-(2-chloroethyl)-N-(2-X-ethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxides with various X substituents have been prepared by cyclization of racemic ifosfamide or its enantiomers with sodium hydride and subsequent treatment of intermed
